Episode 343: ESMO 2024 - TiNivo-2 Trial

By The Uromigos - Last Updated: September 23, 2024

Katy Beckermann discusses the TiNivo-2 study presented at ESMO 2024.

Post Tags:Uromigos Live-Kidney CancerUromigos-ESMO
Advertisement

Related Podcasts

Episode 356: #UromigosLive24 - Front-line Therapy in Papillary and Non-clear Cell RCC
Uromigos Live 2024: Focus on Kidney Cancer
Episode 355: #UromigosLive 24 - Radioligands in Prostate Cancer
Uromigos Live 2024: Focus on Prostate Cancer
Episode 354: #UromigosLive24 - T Cell Directed Therapy in Prostate Cancer by The Uromigos
Uromigos Live 2024: Focus on Prostate Cancer
Episode 353: #UromigosLive24 ADC Session
Uromigos Live 2024: Focus on Bladder Cancer
Episode 352: ESMO 2024 - RCC and Bladder Review
Uromigos-Bladder Cancer
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Contributors and Partners

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Calendar

    Contact Us

    Contribute

    Our Network

    MashupMD

    Cancer Nursing Today

    Urban Health Today

    Blood Cancers Today

    DocWire News

    © 2024 Mashup Media, LLC. All rights reserved.

    Terms of Use | Privacy Policy